The U.S. infant mortality rate declined in 2024 after remaining steady during the waning years of the COVID-19 pandemic. Some health experts attribute this improvement, at least in part, to the new vaccine for respiratory syncytial virus (RSV), which became widely available for prevention of severe RSV among infants and young children during the 2024–2025 respiratory virus season. Provisional data from the Centers for Disease Control and Prevention (CDC) shows the national infant mortality rate …
Read More